发布时间: 2025 - 07 - 22
On July 18, 2025, the 2025 China (Shenzhen) Unicorn Enterprise Conference, themed "New Quality Driven • Future Navigation," was held in Shenzhen. The GEI China Unicorn Enterprise Research Report 2025 and the Shenzhen Unicorn Enterprise and Gazelle Enterprise Research Report 2025 were simultaneously released, revealing the current status and trends of unicorn enterprise development in China and Shenzhen.The reports show that since 2024, the Shenzhen Small and Medium Enterprises Service Bureau has established a Shenzhen Gazelle and Unicorn Enterprise Evaluation Committee to select and ...
浏览次数:3
发布时间: 2025 - 07 - 18
On July 18, the Plant-Derived Recombinant Human Albumin Injection, developed by Wuhan Oryzogen Biotechnology Co., Ltd. using "rice-sourced hematopoiesis" technology, was officially approved for marketing for the treatment of hypoalbuminemia (≤30g/L) associated with liver cirrhosis. Upon market launch, this product will become the first human serum albumin injection in China developed using recombinant protein technology.Currently, human serum albumin drugs used in clinical practice are all derived from human plasma through separation and extraction, which carries risks of resource sh...
浏览次数:5
发布时间: 2025 - 07 - 15
On July 15, 2025, the election congress for the renewal of the Secretary of the Party Branch Committee of Shenzhen Efung Investment Management Enterprise (Limited Partnership) of the Communist Party of China was grandly convened amid the solemn national anthem.In strict accordance with election procedures, Comrade Li Yajing, Managing Director of the Company, was elected Secretary of the new Party Branch Committee of Shenzhen Efung Investment Management Enterprise (Limited Partnership) of the Communist Party of China through secret ballot and competitive election.The newly elected Secretary Li ...
浏览次数:2
发布时间: 2022 - 08 - 10
On August 9, the National Health Commission issued a notice, according to the approval opinions of the State Food and Drug Administration on the application for registration of additional indications for the treatment of novel coronavirus pneumonia with azvudine tablets. In order to further improve the antiviral treatment scheme for novel coronavirus pneumonia, the drug was included in the diagnosis and treatment scheme for novel coronavirus pneumonia (Ninth Edition) through research. The details are as follows:1、 Drug name: Azivudine  2、 Indications It is used to treat adu...
浏览次数:4617
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务